Universe · entity
Novo Holdings A/S
Institutional manager (13F) · CIK 1388325
13F holdings · as of 2026-03-31 · top 22 · reported portfolio $1.2B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | <![CDATA[EDGEWISE THERAPEUTICS INC]]> | $169M | 5,350,000 |
| 2 | <![CDATA[BROOKFIELD CORP]]> | $141M | 3,496,245 |
| 3 | <![CDATA[ASML HOLDING N V]]> | $125M | 94,946 |
| 4 | <![CDATA[MIRUM PHARMACEUTICALS INC]]> | $122M | 1,325,000 |
| 5 | <![CDATA[MAPLIGHT THERAPEUTICS INC]]> | $75M | 3,686,622 |
| 6 | <![CDATA[SALESFORCE INC]]> | $73M | 393,187 |
| 7 | <![CDATA[CRINETICS PHARMACEUTICALS IN]]> | $56M | 1,550,000 |
| 8 | <![CDATA[ENLIVEN THERAPEUTICS INC]]> | $50M | 1,280,000 |
| 9 | <![CDATA[VAXCYTE INC]]> | $50M | 860,000 |
| 10 | <![CDATA[PHARVARIS N V]]> | $49M | 1,750,000 |
| 11 | <![CDATA[ARRIVENT BIOPHARMA INC]]> | $45M | 1,942,142 |
| 12 | <![CDATA[VIRIDIAN THERAPEUTICS INC]]> | $39M | 2,000,000 |
| 13 | <![CDATA[CELLDEX THERAPEUTICS INC NEW]]> | $38M | 1,200,000 |
| 14 | <![CDATA[APOGEE THERAPEUTICS INC]]> | $38M | 450,000 |
| 15 | <![CDATA[BIOMARIN PHARMACEUTICAL INC]]> | $37M | 660,000 |
| 16 | <![CDATA[4D MOLECULAR THERAPEUTICS IN]]> | $34M | 3,650,737 |
| 17 | <![CDATA[ALIBABA GROUP HLDG LTD]]> | $32M | 257,327 |
| 18 | <![CDATA[XENON PHARMACEUTICALS INC]]> | $28M | 485,438 |
| 19 | <![CDATA[BRIDGEBIO ONCOLOGY THERAPEUT]]> | $20M | 2,185,923 |
| 20 | <![CDATA[VALNEVA SE]]> | $7M | 1,057,421 |
| 21 | <![CDATA[LANZATECH GLOBAL INC]]> | $3M | 158,148 |
| 22 | <![CDATA[MARQETA INC]]> | $2M | 441,558 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.